The role of chemotherapy in the treatment of gliomas in adults.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cancer Treatment Reviews

• Publication date

  1989-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0305-7372(89)90007-8PMID 2695239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas

  2005cited by this paper
• Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds

  2005cited by this paper
• Chemotherapy of malignant gliomas

  2005cited by this paper
• Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas

  2005cited by this paper
• Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group study

  2005cited by this paper
• Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery

  2004cited by this paper
• Misonidazole and CCNU chemotherapy for recurrent primary brain tumor

  2004cited by this paper
• High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas

  2004cited by this paper
• Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma

  2004cited by this paper
• Phase 11 study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation

  2004cited by this paper
• Phase I study of intracarotid PCNU

  2004cited by this paper
• Phase I clinical trial of intracarotid bis-chloroethylnitrosourea (BCNU) and 2' dioxy-5-fluorouridine (FUDR) in malignant astrocytomas

  2004cited by this paper
• Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors

  2004cited by this paper
• Cisplatin plus cytosine arabinoside in adults with malignant gliomas

  2004cited by this paper
• Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies

  2004cited by this paper
• Treatment of malignant gliomas in adults with BCNU plus metronidazole

  2004cited by this paper
• Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma

  2004cited by this paper
• Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

  2004cited by this paper
• A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors

  2004cited by this paper
• Phase I study of oral menogaril administered on a once weekly schedule

  1990cited by this paper
• Phase I Study of Weekly Intravenous Administration of Menogaril to Adults with Solid Tumors

  1989cited by this paper
• Non-chemotherapeutic agents that potentiate chemotherapy efficacy.

  1989cited by this paper
• Intratumor Application of Human Leukocyte Interferon-α in Patients with Malignant Brain Tumors

  1989cited by this paper
• Pros and cons of intra-arterial chemotherapy.

  1989cited by this paper
• Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.

  1989cited by this paper
• Brain Tumors and the Blood-Tumor Barrier

  1989cited by this paper
• Intratumor application of human leukocyte interferon-alpha in patients with malignant brain tumors.

  1989cited by this paper
• Phase II Trial of Spirogermanium and Vindesine in Malignant Glioma

  1989cited by this paper
• Response Rate and Toxicity with Aziridinylbenzoquinone in Patients with Recurrent Gliomas A Progress Report

  1988cited by this paper
• Platinum Concentrations in Human Autopsy Tumor Samples

  1988cited by this paper
• Effect of HECNU in malignant supratentorial gliomas — a phase II study

  1988cited by this paper
• A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors

  1988cited by this paper
• Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas.

  1988cited by this paper
• A Phase II Trial of Oral Melphalan in Recurrent Primary Brain Tumors

  1988cited by this paper
• Evaluation of Fludarabine Phosphate in Patients with Recurrent Glioma

  1988cited by this paper
• Successful chemotherapy for recurrent malignant oligodendroglioma

  1988cited by this paper
• Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms.

  1987cited by this paper
• High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.

  1987cited by this paper
• Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.

  1987cited by this paper
• Direct delivery of medication into a brain tumor through multiple chronically implanted catheters.

  1987cited by this paper
• Treatment of Astrocytoma with a 5-Day Cisplatin Infusion

  1987cited by this paper
• Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.

  1987cited by this paper
• Pilot Study of Combination 5‐Fluorouracil, Cisdiamminedichloroplatinum II, and Radiation Therapy for Grade III and IV Astrocytomas

  1987cited by this paper
• Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas.

  1987cited by this paper
• Optimizing drug delivery to brain tumors.

  1987cited by this paper
• Phase II trial of spirogermanium in central nervous system tumors: a Southwest Oncology Group Study.

  1987cited by this paper
• Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors.

  1987cited by this paper
• Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas.

  1987cited by this paper
• Combined intraarterial and systemic chemotherapy for intracerebral tumors.

  1987cited by this paper
• Simultaneous radio- and chemotherapy of inoperable brain tumours.

  1987cited by this paper
• Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation.

  1987cited by this paper
• Human Central Nervous System Pharmacology of Antineoplastic Agents: Implications for the Treatment of Brain Tumors

  1987cited by this paper
• Randomized controlled study of the effect of adjuvant immunotherapy with Picibanil on 51 malignant gliomas.

  1987cited by this paper
• Intracarotid VP-16 in malignant brain tumors

  1987cited by this paper
• Comprehensive phase II evaluation of Aziridinylbenzoquinone (AZQ, Diaziquone) in recurrent human primary brain tumors

  1987cited by this paper
• Phase II trial of interferon-β for treatment of recurrent glioblastoma multiforme

  1986cited by this paper
• Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.

  1986cited by this paper
• Supraophthalmic intracarotid infusion of BCNU for malignant glioma

  1986cited by this paper
• Cisplatin, arabinofuranosyl cytosine, and caffeine before radiation for glioblastomas

  1986cited by this paper
• Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.

  1986cited by this paper
• Phase II trial of interferon-beta for treatment of recurrent glioblastoma multiforme.

  1986cited by this paper
• Northern California Oncology Group protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme.

  1986cited by this paper
• Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas.

  1986cited by this paper
• Phase II Trial of Intracarotid BCNU and Cisplatin in Primary Malignant Brain Tumors

  1986cited by this paper
• Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.

  1986cited by this paper
• Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study.

  1986cited by this paper
• Phase I study of intraarterial mitomycin-c for recurrent intracerebral tumors

  1986cited by this paper
• Phase II study of novantrone (mitroxantrone hydrochloride) in adults with grade III-IV astrocytomas

  1986cited by this paper
• High-dose etoposide in the treatment of relapsed primary brain tumors.

  1985cited by this paper
• Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6-dioxodiethylester) in recurring supratentorial malignant brain gliomas - A phase II study

  1985cited by this paper
• Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A phase ii study by the illinois cancer council

  1985cited by this paper
• The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.

  1985cited by this paper
• Levamisole in the treatment of glioblastoma multiforme

  1985cited by this paper
• Intra‐arterial and intravenous chemotherapy for the treatment of malignant glioma: Preliminary results

  1985cited by this paper
• Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

  1985cited by this paper
• Phase II trial of mitogauzone in malignant primary brain tumors.

  1985cited by this paper
• Phase II trial of mitoqauzone in malignant primary brain tumors

  1985cited by this paper
• Clinical Results of Leukocyte Interferon-Induced Tumor Regression in Resistant Human Metastatic Cancer Resistant to Chemotherapy and/or Radiotherapy-Pulse Therapy Schedule

  1985cited by this paper
• Treatment of patients with recurrent primary brain tumors with AZQ

  1984cited by this paper
• Intracarotid Chemotherapy with a Combination of 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-Diaminedichloroplatinum (Cisplatin), and 4'-O-Demethyl-1-O-(4,6-O-2-thenylidene-β-D-glucopyranosyl)epipodophyllotoxin (VM-26) in the Treatment of Primary and Metastatic Brain Tumors

  1984cited by this paper
• Perioperative carmustine chemotherapy for malignant brain tumors.

  1984cited by this paper
• Phase II trial of prednimustine in glioblastoma multiforme.

  1984cited by this paper
• Lonidamine in Primary Malignant Brain Tumors

  1984cited by this paper
• Intracarotid infusion of cis‐diamminedichloroplatinum in the treatment of recurrent malignant brain tumors

  1984cited by this paper
• Lonidamine in primary malignant brain tumors. Preliminary report.

  1984cited by this paper
• High Dose Chemotherapy with Autologous Bone Marrow Rescue for High Grade Gliomas of the Brain: A Potential for Improvement in Therapeutic Results

  1984cited by this paper
• Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

  1984cited by this paper
• Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.

  1984cited by this paper
• [Effect of MCNU on brain tumors. Part II: Clinical experience with MCNU on malignant brain tumors].

  1984cited by this paper
• Carmustine and Baker's antifol combination chemotherapy for primary brain tumors progressive after irradiation and chemotherapy.

  1984cited by this paper
• PCNU treatment for recurrent malignant gliomas.

  1984cited by this paper
• Phase II evaluation of vindesine in the treatment of malignant glioma.

  1984cited by this paper
• Phase II evaluation of vindesine in the treatment of malignant glioma.

  1984cited by this paper
• Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.

  1984cited by this paper
• Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.

  1984cited by this paper
• Novel modes of chemotherapy administration.

  1984cited by this paper
• Effect of human leukocyte interferon on malignant brain tumors

  1983cited by this paper
• A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors

  1983cited by this paper
• Autologous bone-marrow transplantation: host effects of high-dose BCNU.

  1983cited by this paper
• Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study

  1983cited by this paper

• miR-374a Inhibitor Enhances Etoposide-Induced Cytotoxicity Against Glioma Cells Through Upregulation of FOXO1.

  2019cites this paper
• Downregulation of miR-125b promotes resistance of glioma cells to TRAIL through overexpression of Tafazzin which is a mitochondrial protein

  2019cites this paper
• Inhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells

  2015cites this paper
• Engineered nanocarriers of doxorubicin: a current update.

  2008cites this paper
• Overexpressed WAFl / Cipl Renders Glioblastoma Cells Resistant to Chemotherapy Agents l , 3-Bis ( 2-chloroethyl )-l-nitrosourea and Cisplatin 1

  2006cites this paper
• A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults

  2005cites this paper
• Role of 06-Methylguanine-DNA Methyltransferase in Resistance of Human Brain Tumor Cell Lines to the Clinically Relevant Methylating Agents Temozolomide and Streptozotocin1

  2005cites this paper
• Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats

  2005cites this paper
• The basis for current treatment recommendations for malignant gliomas

  2005cites this paper
• A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors

  2005cites this paper
• Phase 1 study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

  2003cites this paper
• Clinical immunotherapy for brain tumors.

  2002cites this paper
• Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.

  2002cites this paper
• sources and effects of ionizing radiation

  2000cites this paper
• Chemotherapy for adults with malignant glioma.

  1999cites this paper
• Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.

  1999cites this paper
• Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties.

  1999cites this paper
• Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives

  1999cites this paper
• Blood-brain barrier permeability to small and large molecules.

  1999cites this paper
• Concomitant chemoradiotherapy for incompletely resected supratentorial low-grade astrocytoma in children: preliminary report.

  1999cites this paper
• Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide

  1999cites this paper
• Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC)

  1998cites this paper
• Practical guidelines for the treatment of malignant gliomas.

  1998cites this paper
• Attenuation of WAF 1 / Cip 1 Expression by an Antisense Adenovirus Expression Vector Sensitizes Glioblastoma Cells to Apoptosis Induced by Chemotherapeutic Agents 1 , 3-Bis ( 2-chloroethyl )-1-nitrosourea and Cisplatin 1

  1998cites this paper
• Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.

  1998cites this paper
• Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.

  1997cites this paper
• Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas.

  1997cites this paper
• Cranial radiation and concomitant cisplatin and mitomycin-C plus resistance modulators for malignant gliomas

  1997cites this paper
• [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].

  1997cites this paper
• Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

  1997cites this paper
• Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.

  1997cites this paper
• Original Paper Etoposide and Thiotepa Followed by ABMT (Autologous Bone Marrow Transplantation) in Children and Young Adults with High-grade Gliomas

  1997cites this paper
• Phase II trial with BCNU plus α-interferon in patients with recurrent high-grade gliomas

  1997cites this paper
• Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.

  1996cites this paper
• Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumors: possible significance in nitrosourea therapy.

  1996cites this paper
• O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.

  1996cites this paper
• The Charing Cross Hospital experience with temozolomide in patients with gliomas.

  1996cites this paper
• Qualities in the short life : psychological studies relevant to patient and spouse in malignant glioma

  1996cites this paper
• Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.

  1995cites this paper
• Fotemustine in patients with relapsing malignant gliomas - a phase-ii trial.

  1995cites this paper
• The characterization of nuclear-DNA content, the proliferative activity and the immunohistochemical expression of gfap, vim, leu-7, s-100, p53 and cathepsin-d in human glioblastoma multiformes (hgbms) versus human gbm cell-lines grafted into the brains of nude-mice.

  1995cites this paper
• [Chemotherapy of brain tumors: biological basis of its limited efficacy].

  1994cites this paper
• Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.

  1994cites this paper
• Practical Therapeutic Guidelines for the Chemotherapy of Malignant Gliomas

  1994cites this paper
• Cisplatin and radiation in the treatment of tumors of the central nervous system: pharmacological considerations and results of early studies.

  1994cites this paper
• Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

  1993cites this paper
• Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry.

  1993cites this paper
• Supraophthalmic chemotherapy with long tapered catheter: distribution evaluated with intraarterial and intravenous Tc-99m HMPAO.

  1993cites this paper
• PET Studies on Amino Acid Metabolism and Protein Synthesis

  1993cites this paper
• The therapeutic challenge of gliomas.

  1993cites this paper
• Phase II study of tiazofurin in gliomas in adults

  1993cites this paper
• Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors

  1993cites this paper
• Tracers for Clinical Evaluation of Gliomas: A Neurologist’s View

  1993cites this paper
• Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.

  1992cites this paper
• The MTT assay for chemosensitivity testing of human tumors of the central nervous system

  1992cites this paper
• The MTT assay for chemosensitivity testing of human tumors of the central nervous system

  1992influential citation
• Neoadjuvant chemotherapy in the treatment of recurrent glioblastomas (GBM)

  1992cites this paper
• Monoclonal antibodies in the treatment of central nervous system malignancies.

  1992cites this paper
• High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience.

  1992cites this paper
• Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults

  1992cites this paper
• Phase I study of intracarotid administration of carboplatin.

  1992cites this paper
• Intracerebral (parenchymal) infusion of methotrexate: report of a case

  1992cites this paper
• Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I‐labelled anti‐tenascin monoclonal antibody BC‐2

  1992cites this paper
• A Method to Quantitatively Measure Transcapillary Transport of Iodinated Compounds in Canine Brain Tumors with Computed Tomography

  1991cites this paper
• Quantitative measurements of capillary transport in human brain tumors by computed tomography

  1991cites this paper
• Chemioterapia intra-arteriosa con carboplatino nel trattamento del glioblastoma multiforme

  1991cites this paper